Pyramid Biosciences is a clinical-stage oncology company dedicated to developing transformative therapies that will improve the lives of patients with cancer.
Location: United States, Massachusetts, Waltham
Employees: 11-50
Total raised: $61.5M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Alpine Mer... | alpinemeri... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 14.10.2021 | Series B | $33.5M | - |
| 01.09.2020 | - | $28M | - |
Mentions in press and media 5
| Date | Title | Description |
| 01.09.2020 | Pyramid Biosciences Receives $28M | WALTHAM, MA, Pyramid Biosciences has announced the close of $28 million funding round. >> Click here for more funding data on Pyramid Biosciences >> To export Pyramid Biosciences funding data to PDF and Excel, click here ... |
| 01.09.2020 | Pyramid Biosciences Raises $28M in Funding | Pyramid Biosciences, Inc., a Waltham, Mass.-based biotechnology company developing new precision therapies focused on the modulation of cell surface receptors, closed $28m USD in funding. The round was supported by Adage Capital Management,... |
| 31.08.2020 | Pyramid Biosciences Secures $28 Million in Funding | WALTHAM, Mass.--(BUSINESS WIRE)--Pyramid Biosciences, Inc., a Boston-based biotechnology company developing new precision therapies focused on the modulation of cell surface receptors, today announced the close of $28 million USD in funding... |
| 31.08.2020 | Pyramid Biosciences Raises $28M in Funding | Pyramid Biosciences, Inc., a Boston, MA-based biotechnology company developing new precision therapies focused on the modulation of cell surface receptors, closed a $28m funding round. The round was supported by Adage Capital Management, Av... |
| 31.08.2020 | Biotech startup Pyramid Biosciences raises $28M in funding for the advancement of its TRK modulator clinical programs in oncology and dermatology | Pyramid Biosciences, a Boston-based biotech startup developing new precision therapies focused on the modulation of cell surface receptors, today announced it has raised $28 million in funding to accelerate the growth of Pyramid Biosciences... |